Drugs and medical devices class actions.

Lawsuits and investigations

• Consolidated (MDL)Bair Hugger Lawsuit: MDL 2666 Status and Who Qualifies

  As of September 2026, MDL 2666 had 8,433 pending cases before Judge Joan N. Ericksen in Minnesota; Solventum, which manages the litigation for 3M, raised its Bair Hugger litigation accrual in the second quarter of 2026, but no global settlement had been announced.

• Consolidated (MDL)Port Catheter Lawsuit: Bard PowerPort MDL 3081 Verdicts and Who Qualifies

  As of September 2026, MDL 3081 had 3,734 pending Bard port cases before Judge David G. Campbell in Arizona, the second bellwether ended in a $40 million plaintiff verdict on September 4, 2026, more trials were set for October 13 and December 1, 2026 and February 2, 2027, and a separate AngioDynamics MDL 3125 had 428 cases.

• DismissedBoner Bears Lawsuit and Male Enhancement Supplement False Advertising Claims

  As of September 2026, the only Boner Bears class action we could verify (Keegan v. Minahan, S.D. Fla.) was dismissed in June 2023, while the FDA posted recalls and warnings for Boner Bears honey and chocolate products in 2026.

• Consolidated (MDL)Breast Implant Cancer Lawsuit: Allergan Biocell BIA-ALCL MDL 2921 and First Trial

  As of September 2026, MDL 2921 had 1,370 pending cases before Judge Brian R. Martinotti in the District of New Jersey, and the court had set the first bellwether trial, Henson v. Allergan, for November 2, 2026; there is no settlement.

• Consolidated (MDL)Cartiva Implant Lawsuit: MDL 3172 Status and Who Qualifies

  As of September 2026, federal Cartiva cases are consolidated in MDL 3172 before Chief Judge Kristine G. Baker in the Eastern District of Arkansas, with 21 actions pending on September 1, 2026, and no global settlement or trial.

• SettledChantix Nitrosamine Lawsuit: $44 Million Settlement and Case Status

  As of September 2026, Pfizer's $44 million class settlement in MDL 3050 is past its September 14, 2026 claim deadline and awaits a final approval hearing on October 13, 2026 before Judge Katherine Polk Failla.

• Consolidated (MDL)Depo-Provera Meningioma Lawsuit: MDL 3140 Settlement Status and Who Qualifies

  As of September 2026, MDL 3140 had 6,403 pending cases before Judge M. Casey Rodgers in the Northern District of Florida, and Pfizer reported a June 2026 agreement in principle expected to resolve a substantial majority of them; final terms had not been made public.

• Consolidated (MDL)Dupixent CTCL Lawsuit: MDL 3180 Status and Who Qualifies

  As of September 2026, MDL 3180 had 35 pending cases before Judge Zahid N. Quraishi in the District of New Jersey, three months after the JPML created it on June 4, 2026; the litigation is at an early stage with no rulings on causation and no settlement.

• Consolidated (MDL)Hernia Mesh Lawsuit 2026: Bard Settlement, Covidien $88 Million Verdict, and Who Qualifies

  As of September 2026, Bard/Davol MDL 2846 had 23,316 pending cases with most covered by a 2024 settlement, Covidien MDL 3029 had 2,453 pending cases after an $88 million bellwether verdict on August 4, 2026, and the Atrium and Ethicon Physiomesh MDLs were largely resolved.

• Lawsuit filedMetformin Lawsuit (NDMA): Settlement, Status, and Who Qualifies

  As of September 2026, the $5.55 million Teva and Granules/Heritage settlements are past their August 5, 2026 claim deadline and awaiting payment, while the economic loss class action continues against Amneal and Walmart in the District of New Jersey.

• Consolidated (MDL)NEC Baby Formula Lawsuit: Similac and Enfamil Preterm Formula Claims

  As of September 2026, about 1,700 NEC lawsuits remain pending after Abbott's August 20, 2026 agreements to resolve roughly 2,000 claims, and Mead Johnson won the first federal MDL jury trial on August 31, 2026.

• Lawsuit filedNitrous Oxide Whippets Injury Lawsuit: Galaxy Gas Cases and Who Qualifies

  As of September 2026, individual injury and wrongful death suits and a proposed class action are pending against Galaxy Gas, other nitrous oxide sellers, and Amazon in several courts, with no MDL, no class certification, and no settlement.

• Lawsuit filedOlympus Endoscope Infection Lawsuit: Duodenoscope Superbug Claims and Who Qualifies

  As of September 2026, Olympus endoscope infection claims proceed as individual lawsuits in state and federal courts with no MDL or class settlement; the FDA blocked imports of 58 Olympus device models in June 2025 over unresolved quality system violations.

• Lawsuit filedOmnipod Lawsuit: 2026 Pod Recalls, Securities Class Action, and Injury Claims

  As of September 2026, a securities class action (Hu v. Insulet, D. Mass.) was pending over statements about Omnipod quality, and attorneys were reviewing injury claims from users of pods in the March 12 and May 26, 2026 Medical Device Corrections; no MDL, injury class action, or settlement existed.

• Consolidated (MDL)Ozempic Lawsuit: Gastroparesis MDL 3094 and NAION Vision Loss MDL 3163

  As of September 2026, MDL 3094 had 4,022 pending gastrointestinal cases and MDL 3163 had 216 pending NAION vision loss cases, both before Judge Karen S. Marston in Philadelphia; a Rule 702 expert hearing on warnings and general causation ran in mid September 2026 and no trial or settlement had occurred.

• Consolidated (MDL)Paragard Lawsuit: IUD Breakage MDL 2974 Status, Trials, and Who Qualifies

  As of September 2026, MDL 2974 had 4,185 pending cases before Judge Leigh Martin May in the Northern District of Georgia; the first bellwether trial ended in a defense verdict on February 3, 2026, the second is set for April 12, 2027, and there is no settlement.

• Lawsuit filedQC Kinetix Lawsuit: Florida Class Action, Financing Claims, and Who Qualifies

  As of September 2026, Estrada v. QC Franchise Group is a proposed class action pending in the Southern District of Florida with no class certified and no settlement; an earlier Illinois suit, Robertson v. QC Franchise Group, was filed in 2023 and later dismissed.

• Consolidated (MDL)Spinal Cord Stimulator Lawsuit: Boston Scientific MDL 3181, Abbott and Nevro Claims

  As of September 2026, Boston Scientific cases were centralized in MDL 3181 before Judge Josephine L. Staton in Los Angeles (29 pending on September 1, 2026), while separate requests for Abbott (MDL 3194) and Nevro (MDL 3195) MDLs were argued to the JPML on September 24, 2026; there is no settlement.

• Consolidated (MDL)Suboxone Tooth Loss Lawsuit: MDL 3092 Status and Who Qualifies

  As of September 2026, MDL 3092 had 1,827 pending cases before Judge J. Philip Calabrese in the Northern District of Ohio, bellwether core discovery was underway, and the first trial setting was March 2028; there was no settlement.